Pages that link to "Q43503382"

The following pages link to Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans. (Q43503382):

Displaying 16 items.

• Galantamine for Alzheimer's disease and mild cognitive impairment (Q24244773) (← links)
• Galantamine for Alzheimer's disease (Q24246158) (← links)
• The pharmacological landscape and therapeutic potential of serine hydrolases (Q26995817) (← links)
• Galantamine: a review of its use in Alzheimer's disease (Q31754077) (← links)
• Traditional pharmacology and medicine in Africa. Ethnopharmacological themes in sub-Saharan art objects and utensils (Q33642860) (← links)
• Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease (Q34144550) (← links)
• A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease (Q35236228) (← links)
• Clinical pharmacokinetics of galantamine (Q35607538) (← links)
• A review on cholinesterase inhibitors for Alzheimer's disease (Q38084168) (← links)
• Galanthamine (Q41119615) (← links)
• Pharmacokinetic rationale for switching from donepezil to galantamine (Q43632873) (← links)
• Synthesis and structure-activity relationships of open D-Ring galanthamine analogues (Q44489597) (← links)
• Galanthamine: pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice (Q48731865) (← links)
• Galanthamine in Alzheimer's disease : a new alternative to tacrine? (Q51548277) (← links)
• Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts (Q73669302) (← links)
• In sito galanthamine extraction during the cultivation of Leucojum aestivum L. shoot culture in two-phase bubble column cultivation system (Q97094863) (← links)